239 related articles for article (PubMed ID: 35305888)
1. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
Gough J; Hall W; Good J; Nash A; Aitken K
Clin Oncol (R Coll Radiol); 2022 May; 34(5):301-312. PubMed ID: 35305888
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
Chetty IJ; Doemer AJ; Dolan JL; Kim JP; Cunningham JM; Dragovic J; Feldman A; Walker EM; Elshaikh M; Adil K; Movsas B; Parikh PJ
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):950-967. PubMed ID: 35901978
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
4. Medical physics challenges in clinical MR-guided radiotherapy.
Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
[TBL] [Abstract][Full Text] [Related]
5. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
6. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer.
Ermongkonchai T; Khor R; Muralidharan V; Tebbutt N; Lim K; Kutaiba N; Ng SP
World J Gastroenterol; 2022 Feb; 28(7):745-754. PubMed ID: 35317275
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
9. The Use of MR-Guided Radiation Therapy for Liver Cancer.
Prime S; Schiff JP; Hosni A; Stanescu T; Dawson LA; Henke LE
Semin Radiat Oncol; 2024 Jan; 34(1):36-44. PubMed ID: 38105091
[TBL] [Abstract][Full Text] [Related]
10. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
11. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
[TBL] [Abstract][Full Text] [Related]
12. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
13. Advancing the treatment of localized prostate cancer with MR-guided radiotherapy.
Reijnen C; Brunenberg EJL; Kerkmeijer LGW
Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):50-52. PubMed ID: 36550217
[TBL] [Abstract][Full Text] [Related]
14. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
La Rosa A; Mittauer KE; Chuong MD; Hall MD; Kutuk T; Bassiri N; McCulloch J; Alvarez D; Herrera R; Gutierrez AN; Tolakanahalli R; Mehta MP; Kotecha R
Med Dosim; 2023 Winter; 48(4):238-244. PubMed ID: 37330328
[TBL] [Abstract][Full Text] [Related]
15. Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls.
Boldrini L; Cusumano D; Cellini F; Azario L; Mattiucci GC; Valentini V
Radiat Oncol; 2019 Apr; 14(1):71. PubMed ID: 31036034
[TBL] [Abstract][Full Text] [Related]
16. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.
Poon DMC; Yang B; Geng H; Wong OL; Chiu ST; Cheung KY; Yu SK; Chiu G; Yuan J
J Cancer Res Clin Oncol; 2023 Feb; 149(2):841-850. PubMed ID: 35199189
[TBL] [Abstract][Full Text] [Related]
17. Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience.
Boldrini L; Piras A; Chiloiro G; Autorino R; Cellini F; Cusumano D; Fionda B; D'Aviero A; Campitelli M; Marazzi F; Balducci M; Valentini V; Gambacorta MA
Tumori; 2020 Dec; 106(6):497-505. PubMed ID: 32066345
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review.
Ladbury C; Amini A; Schwer A; Liu A; Williams T; Lee P
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296879
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
[TBL] [Abstract][Full Text] [Related]
20. A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Bordeau K; Michalet M; Dorion V; Keskes A; Valdenaire S; Debuire P; Cantaloube M; Cabaillé M; Draghici R; Ychou M; Assenat E; Jarlier M; Gourgou S; Guiu B; Ursic-Bedoya J; Aillères N; Fenoglietto P; Azria D; Riou O
Radiother Oncol; 2023 Dec; 189():109912. PubMed ID: 37739315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
